METCB vs. ALT

Last updated Apr 1, 2026

Compare and contrast key facts about Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT).

Performance

METCB vs. ALT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT). The values are adjusted to include any dividend payments, if applicable.

METCB vs. ALT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
METCB Ramaco Resources Inc.	-12.15%	25.90%	-17.35%	24.77%
ALT Altimmune, Inc.	-14.68%	-49.93%	-35.91%	170.43%

Fundamentals

EPS METCB : -$1.55 ALT : -$0.97
PS Ratio METCB : 0.63 ALT : 6.80K
Total Revenue (TTM) METCB : $536.62M ALT : $41.00K
Gross Profit (TTM) METCB : $23.52M ALT : -$14.95M
EBITDA (TTM) METCB : $13.61M ALT : -$89.46M

Returns By Period

In the year-to-date period, METCB achieves a -12.15% return, which is significantly higher than ALT's -14.68% return.

METCB

• 1D: 0.89%
• 1M: -12.37%
• YTD: -12.15%
• 6M: -38.74%
• 1Y: 50.31%
• 3Y*: —
• 5Y*: —
• 10Y*: —

ALT

• 1D: 6.94%
• 1M: -28.54%
• YTD: -14.68%
• 6M: -18.30%
• 1Y: -38.40%
• 3Y*: -9.96%
• 5Y*: -26.13%
• 10Y*: -40.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

METCB vs. ALT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

METCB

METCB Risk / Return Rank: 63
METCB Sharpe Ratio Rank: 65
METCB Sortino Ratio Rank: 67
METCB Omega Ratio Rank: 61
METCB Calmar Ratio Rank: 64
METCB Martin Ratio Rank: 60

ALT

ALT Risk / Return Rank: 26
ALT Sharpe Ratio Rank: 23
ALT Sortino Ratio Rank: 31
ALT Omega Ratio Rank: 32
ALT Calmar Ratio Rank: 18
ALT Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

METCB vs. ALT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	METCB	ALT	Difference
Sharpe ratio Return per unit of total volatility	0.62	-0.41	+1.04
Sortino ratio Return per unit of downside risk	1.44	0.05	+1.38
Omega ratio Gain probability vs. loss probability	1.16	1.01	+0.15
Calmar ratio Return relative to maximum drawdown	0.97	-0.67	+1.64
Martin ratio Return relative to average drawdown	1.86	-1.02	+2.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

METCB vs. ALT - Sharpe Ratio Comparison

The current METCB Sharpe Ratio is 0.62, which is higher than the ALT Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of METCB and ALT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	METCB	ALT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.62	-0.41	+1.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.28	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	-0.24	+0.32

Correlation

The correlation between METCB and ALT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

METCB vs. ALT - Dividend Comparison

METCB's dividend yield for the trailing twelve months is around 1.74%, while ALT has not paid dividends to shareholders.

	TTM	2025	2024	2023
METCB Ramaco Resources Inc.	1.74%	3.18%	9.36%	3.11%
ALT Altimmune, Inc.	0.00%	0.00%	0.00%	0.00%

Drawdowns

METCB vs. ALT - Drawdown Comparison

The maximum METCB drawdown since its inception was -56.22%, smaller than the maximum ALT drawdown of -99.94%. Use the drawdown chart below to compare losses from any high point for METCB and ALT.

Drawdown Indicators

	METCB	ALT	Difference
Max Drawdown Largest peak-to-trough decline	-56.22%	-99.94%	+43.72%
Max Drawdown (1Y) Largest decline over 1 year	-55.65%	-62.65%	+7.00%
Max Drawdown (5Y) Largest decline over 5 years	—	-90.45%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.85%	—
Current Drawdown Current decline from peak	-52.37%	-99.89%	+47.52%
Average Drawdown Average peak-to-trough decline	-27.90%	-80.66%	+52.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.84%	41.12%	-12.28%

Volatility

METCB vs. ALT - Volatility Comparison

The current volatility for Ramaco Resources Inc. (METCB) is 19.76%, while Altimmune, Inc. (ALT) has a volatility of 26.59%. This indicates that METCB experiences smaller price fluctuations and is considered to be less risky than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	METCB	ALT	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.76%	26.59%	-6.83%
Volatility (6M) Calculated over the trailing 6-month period	57.98%	58.39%	-0.41%
Volatility (1Y) Calculated over the trailing 1-year period	80.94%	93.96%	-13.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	65.17%	94.38%	-29.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.17%	142.47%	-77.30%

Financials